• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1号染色体短臂、2号染色体短臂、6号染色体短臂、10号染色体短臂、13号染色体长臂、17号染色体短臂和21号染色体长臂上的等位基因缺失与肾细胞癌的嫌色细胞亚型显著相关。

Allelic losses at chromosomes 1p, 2p, 6p, 10p, 13q, 17p, and 21q significantly correlate with the chromophobe subtype of renal cell carcinoma.

作者信息

Schwerdtle R F, Störkel S, Neuhaus C, Brauch H, Weidt E, Brenner W, Hohenfellner R, Huber C, Decker H J

机构信息

Department of Hematology, Johannes Gutenberg University, Mainz, Germany.

出版信息

Cancer Res. 1996 Jul 1;56(13):2927-30.

PMID:8674042
Abstract

We analyzed 50 sporadic renal cell carcinomas (RCCs) for loss of heterozygosity (LOH) at the chromosomal regions 1p, 2p, 6p, 7q, 10p, 11p, 13q, 14q, 17p, 21q, and 22q. Histologically, the tumors were distinguished into clear cell, chromophilic, and chromophobe carcinomas. Whereas LOH at 14q was identified in 42-64% of all three tumor types, only the chromophobe tumors showed high frequencies of LOH (73-91%) at 1p, 2p, 6p, 10p, 13q, 17p, and 21q. These findings provide substantial evidence that the chromophobe subtype of RCC represents a distinct genetic entity. Thus, specific LOH patterns may define the histogenesis and oncogenesis of chromophobe RCC and may be useful in tumor diagnosis and clinical prognosis.

摘要

我们分析了50例散发性肾细胞癌(RCC),以检测1p、2p、6p、7q、10p、11p、13q、14q、17p、21q和22q染色体区域的杂合性缺失(LOH)情况。在组织学上,这些肿瘤被区分为透明细胞癌、嗜酸性细胞癌和嫌色细胞癌。虽然在所有三种肿瘤类型中,14q的LOH发生率为42%-64%,但只有嫌色细胞肿瘤在1p、2p、6p、10p、13q、17p和21q显示出高频率的LOH(73%-91%)。这些发现提供了充分的证据,表明RCC的嫌色细胞亚型代表一种独特的遗传实体。因此,特定的LOH模式可能界定嫌色细胞RCC的组织发生和肿瘤发生,并且可能有助于肿瘤诊断和临床预后判断。

相似文献

1
Allelic losses at chromosomes 1p, 2p, 6p, 10p, 13q, 17p, and 21q significantly correlate with the chromophobe subtype of renal cell carcinoma.1号染色体短臂、2号染色体短臂、6号染色体短臂、10号染色体短臂、13号染色体长臂、17号染色体短臂和21号染色体长臂上的等位基因缺失与肾细胞癌的嫌色细胞亚型显著相关。
Cancer Res. 1996 Jul 1;56(13):2927-30.
2
Loss of heterozygosity studies and deletion mapping identify two putative chromosome 14q tumor suppressor loci in renal oncocytomas.杂合性缺失研究和缺失图谱分析确定了肾嗜酸细胞瘤中两个假定的14号染色体q臂肿瘤抑制基因座。
Cancer Res. 1997 Nov 15;57(22):5009-12.
3
Microsatellite allelotyping differentiates chromophobe renal cell carcinomas from renal oncocytomas and identifies new genetic changes.微卫星等位基因分型可区分嫌色性肾细胞癌与肾嗜酸细胞瘤,并识别新的基因变化。
Histopathology. 2004 Jun;44(6):542-6. doi: 10.1111/j.1365-2559.2004.01884.x.
4
Allelic losses at chromosome 17p in human renal cell carcinoma are inversely related to allelic losses at chromosome 3p.人类肾细胞癌中17号染色体短臂的等位基因缺失与3号染色体短臂的等位基因缺失呈负相关。
Cancer Res. 1992 Apr 1;52(7):1881-5.
5
Loss of heterozygosity on the long arm of human chromosome 7 in sporadic renal cell carcinomas.散发性肾细胞癌中人类7号染色体长臂杂合性缺失
Oncogene. 1997 Nov 27;15(22):2727-33. doi: 10.1038/sj.onc.1201448.
6
Inactivation of BHD in sporadic renal tumors.散发性肾肿瘤中BHD的失活
Cancer Res. 2003 Aug 1;63(15):4583-7.
7
Correlations of allelic imbalance of chromosome 14 with adverse prognostic parameters in 148 renal cell carcinomas.148例肾细胞癌中14号染色体等位基因失衡与不良预后参数的相关性
Genes Chromosomes Cancer. 1996 Dec;17(4):215-24. doi: 10.1002/(SICI)1098-2264(199612)17:4<215::AID-GCC3>3.0.CO;2-6.
8
Lack of genetic changes at specific genomic sites separates renal oncocytomas from renal cell carcinomas.特定基因组位点缺乏基因变化可将肾嗜酸细胞瘤与肾细胞癌区分开来。
J Pathol. 1998 Jan;184(1):58-62. doi: 10.1002/(SICI)1096-9896(199801)184:1<58::AID-PATH987>3.0.CO;2-1.
9
Loss of heterozygosity at chromosomes 8p, 9p, and 14q is associated with stage and grade of non-papillary renal cell carcinomas.8号染色体短臂、9号染色体短臂和14号染色体长臂杂合性缺失与非乳头状肾细胞癌的分期和分级相关。
J Pathol. 1997 Oct;183(2):151-5. doi: 10.1002/(SICI)1096-9896(199710)183:2<151::AID-PATH928>3.0.CO;2-R.
10
Allelic deletions in renal tumors: histopathological correlations.肾肿瘤中的等位基因缺失:组织病理学相关性
Cancer Res. 1993 Dec 1;53(23):5780-3.

引用本文的文献

1
Renal Cell Carcinoma in the Era of Precision Medicine: From Molecular Pathology to Tissue-Based Biomarkers.精准医学时代的肾细胞癌:从分子病理学到基于组织的生物标志物
J Clin Oncol. 2018 Oct 29;36(36):JCO2018792259. doi: 10.1200/JCO.2018.79.2259.
2
Genetic and Chromosomal Aberrations and Their Clinical Significance in Renal Neoplasms.肾脏肿瘤中的遗传和染色体畸变及其临床意义
Biomed Res Int. 2015;2015:476508. doi: 10.1155/2015/476508. Epub 2015 Sep 13.
3
Genetic architecture of renal cell carcinoma: Do we have to know?肾细胞癌的遗传结构:我们有必要了解吗?
World J Urol. 2016 Jun;34(6):765-9. doi: 10.1007/s00345-015-1697-y. Epub 2015 Sep 28.
4
Tumour and patient factors in renal cell carcinoma-towards personalized therapy.肾细胞癌的肿瘤和患者因素——走向个体化治疗。
Nat Rev Urol. 2015 May;12(5):253-62. doi: 10.1038/nrurol.2015.71. Epub 2015 Apr 14.
5
Chromophobe renal cell carcinoma--chromosomal aberration variability and its relation to Paner grading system: an array CGH and FISH analysis of 37 cases.嫌色细胞性肾细胞癌--染色体畸变的可变性及其与 Paner 分级系统的关系:37 例的 array CGH 和 FISH 分析。
Virchows Arch. 2013 Oct;463(4):563-73. doi: 10.1007/s00428-013-1457-6. Epub 2013 Aug 3.
6
Chromophobe renal cell carcinoma: useful diagnostic application of imprint cytology and fluorescence in situ hybridization of chromosomes 10 and 21 in two cases of typical and eosinophilic variants.嫌色性肾细胞癌:印片细胞学及10号和21号染色体荧光原位杂交在两例典型及嗜酸性变体病例中的诊断应用
Med Mol Morphol. 2008 Dec;41(4):227-32. doi: 10.1007/s00795-008-0406-y. Epub 2008 Dec 24.
7
Analysis of the ANA gene as a candidate for the chromosome 21q oral cancer susceptibility locus.分析ANA基因作为21号染色体q臂口腔癌易感位点的候选基因。
Br J Cancer. 2001 Mar 23;84(6):754-9. doi: 10.1054/bjoc.2000.1656.
8
Allelic imbalance and instability of microsatellite loci on chromosome 1p in human non-small-cell lung cancer.人类非小细胞肺癌中1号染色体短臂上微卫星位点的等位基因不平衡与不稳定性。
Br J Cancer. 1998 May;77(10):1604-11. doi: 10.1038/bjc.1998.263.